The EPISTOP-IDEAL (H2020) project, where Prof. Ralf-Dieter Hilgers is collaborating with four other European universities, was selected to receive funding from the European Joint Programme on Rare Diseases (EJP RD) to demonstrate the added value of statistical methods to design and analyse small population clinical trials from IDeAl to re-evaluate the results of the EPISTOP project in Tuberous sclerosis complex.
EPISTOP-IDEAL project funded by EJP-RD
Uniklinik RWTH Aachen
Dr. Mathias Brandstädter
Tel. 0241 80-89893